FDA/PhRMA May Create Database Of Hepatotoxins

A pharmaceutical consortium could create a hepatotoxin database within the next 12 to 18 months, members of the FDA/PhRMA Hepatotoxicity Steering Committee suggested during a Nov. 8 meeting

More from Archive

More from Pink Sheet